Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
Clinical trial NCT03215927 · COMPLETED
Trial details
- NCT number
- NCT03215927
- Sponsor
- Rohit Aggarwal, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2022-05-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.